Conflict-of-Interest Guidelines for a Multicenter Clinical Trial of Treatment after Coronary-Artery Bypass-Graft Surgery

The participation of industry in university-based biomedical research has greatly increased in recent years. On the principle that industry should participate in the funding of research from which it may derive benefit, such collaboration is appropriate. The transformation of technology from basic and clinical laboratories into useful products with commercial value is an accepted and laudable practice, which provides a sound basis for social, economic, and scientific policy.1 It is recognized that partnerships between university and industry are in the best interests of the country and the research community. With the increase in such relationships, however, there is growing pressure . . .